Customizations Possible - Country-wise reports, Additional company profiles, Country/Regional reports and Other Customizations. Special Discounts Available. Global Minimally Invasive Cardiac Surgery Market Size & Trends Report Segmented by Surgery Type (Robotic-assisted, Thoracoscopic), Procedure (AVR, TVR, MVR, ASD, CABG), End User (Hospitals, Specialty Clinics) & Regional Forecast to 2030

Global Minimally Invasive Cardiac Surgery Market Size & Trends Report Segmented by Surgery Type (Robotic-assisted, Thoracoscopic), Procedure (AVR, TVR, MVR, ASD, CABG), End User (Hospitals, Specialty Clinics) & Regional Forecast to 2030

The minimally invasive cardiac surgery market is projected to grow at a 5-10% CAGR over the forecast period. Major factors driving growth include increased prevalence of cardiovascular diseases (CVDs), rising demand for minimally invasive cardiac procedures, growing aging population, patient preference for minimally invasive procedures, technological advancement in minimally invasive cardiac surgery, shift towards outpatient and ambulatory surgery centers (ASCs), and rising awareness about cardiovascular health conditions. To learn more about the research report, download a sample report.

Report Overview

Minimally invasive cardiac surgery (MICS), sometimes referred to as keyhole heart surgery, is a sophisticated technique used to perform heart bypass procedures for treating coronary heart disease. In this approach, the surgeon uses specialized surgical instruments to access the heart through a small incision on the left side of the chest. Unlike traditional open-heart surgery, which requires opening the chest cavity, MICS allows access through the natural spaces between the ribs without the need for cutting. This method is less invasive, resulting in reduced trauma and quicker patient recovery.

To learn more about the research report, download a sample report.

Growing demand for minimally invasive cardiac surgery procedures fuels its demand

Minimally invasive cardiac procedures have revolutionized heart surgery by offering safer and less invasive alternatives to traditional open-heart techniques. The adoption of these methods is rapidly growing, driven by the need to reduce patient trauma, shorten recovery times, and lower healthcare costs. Procedures like cardiac catheterization and percutaneous coronary intervention are increasingly preferred due to their significant benefits over conventional approaches. These techniques utilize specialized cardiology devices, such as catheters, stents, and guidewires, which are witnessing rising demand. Moreover, minimally invasive approaches are widely applied in various cardiac surgeries, including mitral valve repair, coronary artery bypass grafting, and aortic valve replacement, further accelerating market growth.

To learn more about the research report, download a sample report.

Shift towards minimally invasive cardiac surgery over traditional heart surgery drives market growth

Minimally invasive cardiac surgery (MICS) has transformed the treatment of various heart conditions, offering a safer and equally effective alternative to traditional open-heart surgery. It provides several significant advantages over conventional methods:

Smaller Incisions & Less Pain: With minimal incisions on the breastbone, MICS reduces post-operative pain and scarring. This approach also preserves chest function and improves breathing after surgery
Faster Recovery & Return to Daily Activities: Unlike traditional heart surgeries, MICS allows patients to resume normal activities, such as driving and working, much sooner often immediately after the initial recovery phase
Minimal Blood Loss & Reduced Need for Transfusion: The use of robotic instruments and small incisions minimizes blood loss during the procedure, significantly lowering the need for transfusions and reducing the risk of blood-borne infections
Lower Risk of Post-Surgical Infections: Due to the smaller incisions, MICS greatly decreases the likelihood of infections, making it particularly beneficial for diabetic and elderly patients with weaker immune systems
Minimal Scarring & Faster Healing: With incisions as small as 2-4 inches, scarring is virtually non-existent, leading to quicker wound healing with fewer complications
Shorter Hospital Stays: One of the greatest advantages of MICS is the reduced recovery period. Patients typically stay in the hospital for about five days, compared to nine days for those undergoing traditional open-heart surgery, enabling a faster return to normal life with less rehabilitative care.

By combining advanced surgical techniques with enhanced patient outcomes, MICS continues to redefine the landscape of modern cardiac surgery.

Competitive Landscape Analysis

The global minimally invasive cardiac surgery market is marked by the presence of established and emerging market players such as Abbott Laboratories; Intuitive Surgical; Stryker Corporation; GE HealthCare; Edwards Lifesciences Corporation; Siemens Healthineers; Terumo Corporation; Johnson & Johnson; Philips Healthcare; Medtronic; Boston Scientific Corporation; Zimmer Biomet; Smith & Nephew; Olympus Corporation; and Micro Interventional Devices (MID); among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

Report Scope

Report Scope	Details
Base Year Considered	2024
Historical Data	2023 - 2024
Forecast Period	2025 - 2030
Growth Rate	5-10%
Market Drivers	Increased prevalence of cardiovascular diseases (CVDs) Rising demand for minimally invasive procedures Growing aging population Technological advancement in minimally invasive procedures Shift towards outpatient and ambulatory surgery centers (ASCs)
Attractive Opportunities	Expansion of robotic-assisted cardiac surgery Increasing adoption of hybrid operating rooms Growing focus on outpatient & ambulatory surgery centers (ASCs) Development of next-generation heart valves & stents
Segment Scope	Surgery Type, Procedure Type, and End User
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Abbott Laboratories; Intuitive Surgical; Stryker Corporation; GE HealthCare; Edwards Lifesciences Corporation; Siemens Healthineers; Terumo Corporation; Johnson & Johnson; Philips Healthcare; Medtronic; Boston Scientific Corporation; Zimmer Biomet; Smith & Nephew; Olympus Corporation; and Micro Interventional Devices (MID)
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Market Segmentation

This report by Medi-Tech Insights provides the size of the global minimally invasive cardiac surgery market at the regional- and country-level from 2023 to 2030. The report further segments the market based on surgery type, procedure type, and end user.

Market Size & Forecast (2023-2030), By Surgery Type, USD Million
- Robotic-assisted Surgery
- Thoracoscopy Surgery
Market Size & Forecast (2023-2030), By Procedure Type, USD Million
- Aortic Valve Repair/Replacement
- Mitral Valve Repair/Replacement
- Surgical Radiofrequency Ablation for Atrial Fibrillation
- Tricuspid Valve Repair or Replacement
- Atrial Septal Defect (ASD)
- Ventricular Assist Device (VAD) Implantation
- Coronary Artery Bypass Grafting (CABG)
- Other Procedures
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Speciality Clinics
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
  - US
  - Canada
- Europe
  - UK
  - Germany
  - France
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Rest of Asia Pacific
- Latin America
- Middle East & Africa

Key Strategic Questions Addressed

What is the market size & forecast of the minimally invasive cardiac surgery market?
What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the minimally invasive cardiac surgery market?
What are the key trends defining the market?
What are the major factors impacting the market?
What are the opportunities prevailing in the market?
Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
Who are the major players operating in the market?
What are the key strategies adopted by players?

Introduction
- Introduction
- Market Scope
  - Market Definition
  - Segments Covered
  - Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
  - Bottom-Up Approach
  - Top-Down Approach
- Market Forecasting
Executive Summary
- Minimally Invasive Cardiac Surgery Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
Market Overview
- Market Dynamics
- Drivers
  - Increased prevalence of cardiovascular diseases (CVDs)
  - Rising demand for minimally invasive procedures
  - Gowing aging population
  - Technological advancement in minimally invasive procedures
  - Shift towards outpatient and ambulatory surgery centers (ASCs)
- Restraints
  - High cost of advanced technology and specialized equipment required for MICS, limiting accessibility in low-income regions
  - Training and expertise required for surgery
- Opportunities
  - Expansion of robotic-assisted cardiac surgery
  - Increasing adoption of hybrid operating rooms
  - Growing focus on outpatient & ambulatory surgery centers (ASCs)
  - Development of next-generation heart valves & stents
- Key Market Trends
  - Advancements in minimally invasive ventricular assist devices (VADs)
  - Increasing usage of 3D printing & personalized medicine
  - Integration of AI-powered diagnostics & robotic-assisted procedures
- Unmet Market Needs
- Industry Speaks
Global Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), By Surgery Type, USD Million
- Introduction
- Robotic-assisted Surgery
- Thoracoscopic Surgery
Global Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), By Procedure Type, USD Million
- Introduction
- Aortic Valve Repair/Replacement
- Mitral Valve Repair/Replacement
- Surgical Radiofrequency Ablation for Atrial Fibrillation
- Tricuspid Valve Repair or Replacement
- Atrial Septal Defect (ASD)
- Ventricular Assist Device (VAD) Implantation
- Coronary Artery Bypass Grafting (CABG)
- Other Procedures
Global Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Speciality Clinics
- Others
Global Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), By Country, USD Million
  - US
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Canada
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
- Europe Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), By Country, USD Million
  - UK
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Germany
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - France
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Italy
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Spain
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Rest of Europe
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
- Asia Pacific (APAC) Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), By Country, USD Million
  - China
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Japan
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - India
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Rest of Asia Pacific
    - Market Size & Forecast, By Surgery Type (USD Million)
    - Market Size & Forecast, By Procedure Type (USD Million)
    - Market Size & Forecast, By End User (USD Million)
- Latin America (LATAM) Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), USD Million
  - Market Size & Forecast, By Surgery Type (USD Million)
  - Market Size & Forecast, By Procedure Type (USD Million)
  - Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Minimally Invasive Cardiac Surgery Market Size & Forecast (2023-2030), USD Million
  - Market Size & Forecast, By Surgery Type (USD Million)
  - Market Size & Forecast, By Procedure Type (USD Million)
  - Market Size & Forecast, By End User (USD Million)
Competitive Landscape
- Key Players and their Competitive Positioning
  - Key Player Comparison
  - Segment-wise Player Mapping
  - Market Share Analysis (2024)
  - Company Categorization Matrix
    - Dominants/Leaders
    - New Entrants
    - Emerging Players
    - Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
  - New Product Launches
  - Partnerships, Agreements, & Collaborations
  - Mergers & Acquisitions
  - Geographic Expansion
Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Abbott Laboratories
- GE HealthCare
- Edwards Lifesciences Corporation
- Siemens Healthineers
- Medtronic
- Boston Scientific Corporation
- Intuitive Surgical
- Stryker Corporation
- Terumo Corporation
- Johnson & Johnson
- Other Prominent Players

Note: *Indicative list

**For listed companies

The study has been compiled based on extensive primary and secondary research.

Secondary Research (Indicative List)

Primary Research

To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.

Supply Side Stakeholders:

Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants

Demand Side Stakeholders:

Stakeholders from Hospitals, Ambulatory Surgical Centers (ASCs), Speciality Clinics, and Others

Breakdown of Primary Interviews

Market Size Estimation

Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts.

Data Triangulation

Research findings derived through secondary sources & internal analysis were validated with Primary Interviews, the Internal Knowledge Repository, and the Company’s Sales Data.